Acquisition strengthens clinic portfolio for mental health treatment using psychedelic-assisted therapies VANCOUVER, BC, Sept. 23, 2021 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced it has closed its acquisition of the Neurology Centre of…

Source

Previous articleAwakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial College London
Next articlePTSF78 – Navigating the Vast Psychedelic Space: Where Do You Fit In?